Corticobasal Degeneration clinical trials at UCSF
2 in progress, 1 open to eligible people
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
open to eligible people ages 18 years and up
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.
San Francisco, California and other locations
Rho Kinase (ROCK) Inhibitor in Tauopathies - 1
Sorry, in progress, not accepting new patients
A Phase 2a Open-Label Preliminary Safety, Tolerability, and Biomarker Study of Oral Fasudil in Patients with the 4-Repeat Tauopathies of Progressive Supranuclear Palsy-Richardson Syndrome or Corticobasal Syndrome
San Francisco, California
Our lead scientists for Corticobasal Degeneration research studies include Peter Ljubenkov Howie Rosen, MD Adam Boxer, MD, PhD.
Last updated: